Baseline Hepamet fibrosis score is associated with type 2 diabetes remission after bariatric surgery

Simple item page
dc.contributor.authorMartínez Montoro, José Ignacio
dc.contributor.authorPinazo Bandera, José M.
dc.contributor.authorGarcía Serrano, Sara
dc.contributor.authorGarcía Almeida, José Manuel
dc.contributor.authorOcaña Wilhelmi, Luis
dc.contributor.authorMoreno Ruiz, Francisco Javier
dc.contributor.authorSoler Humanes, Rocío
dc.contributor.authorRuiz Campos, Nerea
dc.contributor.authorSancho Marín, Raquel
dc.contributor.authorGarcía Cortés, Miren
dc.contributor.authorEt. al.
dc.date.accessioned2026-09-25T09:16:59Z
dc.date.available2026-09-25T09:16:59Z
dc.date.issued2026
dc.description.abstractType 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD) share common pathophysiological mechanisms and exert reciprocal influences on each other. Bariatric surgery (BS) is the most effective treatment for the improvement and resolution of both conditions; however, little is known about the role of MASLD in diabetes remission following BS.en
dc.description.filiationUEMspa
dc.description.impact3.2 Q1 JCR 2025
dc.description.impact1.136 Q1 SJR 2025
dc.description.impactNo data IDR 2024
dc.description.sponsorshipPI-0108-2022
dc.description.sponsorshipPI23/01702
dc.description.sponsorshipCM24/00006
dc.description.sponsorshipConsultar más financiación en 10.1016/j.soard.2026.05.016
dc.identifier.citationMartínez-Montoro, J. I., Pinazo-Bandera, J. M., García-Serrano, S., García-Almeida, J. M., Ocaña-Wilhelmi, L., Moreno-Ruiz, F. J., Soler-Humanes, R., Ruiz-Campos, N., Sancho-Marín, R., García-Cortés, M., Muñoz-Garach, A., Fernández-García, J. C., García-Fuentes, E., Tinahones, F. J., & Garrido-Sánchez, L. (2026). Baseline Hepamet fibrosis score is associated with type 2 diabetes remission after bariatric surgery. Surgery for Obesity and Related Diseases, 22(10), 1140-1147. https://doi.org/10.1016/j.soard.2026.05.016
dc.identifier.doi10.1016/j.soard.2026.05.016
dc.identifier.issn1550-7289
dc.identifier.issn1878-7533
dc.identifier.urihttps://hdl.handle.net/11268/17441
dc.language.isoeng
dc.peerreviewedSi
dc.relation.publisherversionhttp://doi.org/10.1016/j.soard.2026.05.016
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.otherOdontología
dc.subject.otherCirugía Bariátrica
dc.subject.otherDiabetes Mellitus Tipo 2
dc.subject.otherEnfermedad del Hígado Graso no Alcohólico
dc.subject.sdgGoal 3: Ensure healthy lives and promote well-being for all at all ages
dc.subject.unescoSistema endocrino
dc.subject.unescoEnfermedad
dc.subject.unescoCirugía
dc.titleBaseline Hepamet fibrosis score is associated with type 2 diabetes remission after bariatric surgeryen
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Baseline Hepamet fibrosis.pdf
Size:
1.6 MB
Format:
Adobe Portable Document Format
Download

Collections

Área de Ciencias de la Salud